MX2011007065A - Analogos de dicetopiperazina substituida para usarse como agentes de suministro de farmaco. - Google Patents
Analogos de dicetopiperazina substituida para usarse como agentes de suministro de farmaco.Info
- Publication number
- MX2011007065A MX2011007065A MX2011007065A MX2011007065A MX2011007065A MX 2011007065 A MX2011007065 A MX 2011007065A MX 2011007065 A MX2011007065 A MX 2011007065A MX 2011007065 A MX2011007065 A MX 2011007065A MX 2011007065 A MX2011007065 A MX 2011007065A
- Authority
- MX
- Mexico
- Prior art keywords
- drug delivery
- delivery agents
- substituted diketopiperazine
- analogs
- delivery
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Se describen sistemas de suministro de fármaco para el suministro de fármacos de molécula pequeña y macromoleculares. Más particularmente. Se describen análogos substituidos de 3,6- di(alquil-4-aminobutil)-2,5-dicetopiperazina (la cual también puede ser denominada como DKP), su uso en la formulación de fármacos tanto de molécula pequeña como macromoleculares incluyendo agentes terapéuticos, profilácticos y de diagnóstico, agentes de estabilización y sistemas para su suministro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14120708P | 2008-12-29 | 2008-12-29 | |
PCT/US2009/069745 WO2010078373A1 (en) | 2008-12-29 | 2009-12-29 | Substituted diketopiperazine analogs for use as drug delivery agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011007065A true MX2011007065A (es) | 2011-08-03 |
Family
ID=41694085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011007065A MX2011007065A (es) | 2008-12-29 | 2009-12-29 | Analogos de dicetopiperazina substituida para usarse como agentes de suministro de farmaco. |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP2862854A1 (es) |
JP (2) | JP5788806B2 (es) |
CA (1) | CA2748490C (es) |
DK (1) | DK2379511T3 (es) |
ES (1) | ES2531009T3 (es) |
MX (1) | MX2011007065A (es) |
PT (1) | PT2379511E (es) |
SI (1) | SI2379511T1 (es) |
WO (1) | WO2010078373A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
ES2425392T3 (es) | 2002-03-20 | 2013-10-15 | Mannkind Corporation | Cartucho para un aparato de inhalación |
CN101010305B (zh) | 2004-08-20 | 2010-08-11 | 曼金德公司 | 二酮哌嗪合成的催化反应 |
KR101644250B1 (ko) | 2004-08-23 | 2016-07-29 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
AU2006290227B2 (en) | 2005-09-14 | 2012-08-02 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
DK1986679T3 (da) | 2006-02-22 | 2017-11-20 | Mannkind Corp | Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CA2728230C (en) | 2008-06-13 | 2017-10-17 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
AU2009259883B2 (en) | 2008-06-20 | 2015-02-05 | Mannkind Corporation | An interactive apparatus and method for real-time profiling of inhalation efforts |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US8969353B2 (en) | 2008-11-07 | 2015-03-03 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
EP2862854A1 (en) * | 2008-12-29 | 2015-04-22 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
SG176738A1 (en) | 2009-06-12 | 2012-01-30 | Mannkind Corp | Diketopiperazine microparticles with defined specific surface areas |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
EP2582421A1 (en) | 2010-06-21 | 2013-04-24 | MannKind Corporation | Dry powder drug delivery system and methods |
WO2012135025A2 (en) | 2011-03-28 | 2012-10-04 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
ES2625858T3 (es) | 2011-04-01 | 2017-07-20 | Mannkind Corporation | Paquete de tipo blíster para cartuchos farmacéuticos |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
KR102272498B1 (ko) * | 2011-10-27 | 2021-07-06 | 메사추세츠 인스티튜트 오브 테크놀로지 | 약물 캡슐화 마이크로스피어를 형성할 수 있는, n-말단 상에 관능화된 아미노산 유도체 |
CN104284918B (zh) * | 2012-03-28 | 2017-03-29 | 高剑萍 | 氨酯型和脲酯型化合物及其制备方法 |
EP2841422B1 (en) * | 2012-04-27 | 2019-08-28 | MannKind Corporation | Methods for the synthesis of ethylfumarates and their use as intermediates |
WO2014012069A2 (en) * | 2012-07-12 | 2014-01-16 | Mannkind Corporation | Dry powder drug delivery systems and methods |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
EP3587404B1 (en) | 2013-03-15 | 2022-07-13 | MannKind Corporation | Microcrystalline diketopiperazine compositions, methods for preparation and use thereof |
BR112016000937A8 (pt) | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
WO2016004202A1 (en) | 2014-07-02 | 2016-01-07 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
RS64331B1 (sr) | 2015-06-19 | 2023-08-31 | Massachusetts Inst Technology | Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta |
US20220354782A1 (en) * | 2019-09-17 | 2022-11-10 | Cass Pharmaceuticals, Inc. | Subcutaneously injectable insulin and glucagon formulations and methods of administration |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
CA2190502A1 (en) | 1994-05-18 | 1995-11-23 | Robert M. Platz | Methods and compositions for the dry powder formulation of interferons |
US6428771B1 (en) | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
AU5806998A (en) | 1996-12-31 | 1998-07-31 | Inhale Therapeutic Systems | Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
AU2001284697A1 (en) * | 2000-08-04 | 2002-02-18 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
KR20030038690A (ko) | 2000-08-07 | 2003-05-16 | 인헤일 테라퓨틱 시스템즈 인크. | 응집이 최소화된, 흡입성 분무 건조 4-나선 다발 단백질분말 |
CA2432175C (en) | 2000-12-21 | 2010-08-10 | Jayne E. Hastedt | Storage stable powder compositions of interleukin-4 receptor |
JP4663906B2 (ja) * | 2001-04-26 | 2011-04-06 | 富士フイルム株式会社 | セルロースアシレートフイルム |
US6838076B2 (en) | 2001-05-21 | 2005-01-04 | Nektar Therapeutics | Pulmonary administration of chemically modified insulin |
KR20070057829A (ko) | 2004-08-23 | 2007-06-07 | 맨카인드 코포레이션 | 포스포디에스테라아제 5형의 억제제의 폐 전달 |
KR101644250B1 (ko) | 2004-08-23 | 2016-07-29 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
AU2006290227B2 (en) | 2005-09-14 | 2012-08-02 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
DK1986679T3 (da) | 2006-02-22 | 2017-11-20 | Mannkind Corp | Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof |
EP2046778B1 (en) * | 2006-08-04 | 2013-12-04 | Manus Pharmaceuticals (Canada) Ltd. | Multifunctional bioactive compounds |
EP2862854A1 (en) * | 2008-12-29 | 2015-04-22 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
-
2009
- 2009-12-29 EP EP20140192154 patent/EP2862854A1/en not_active Withdrawn
- 2009-12-29 CA CA2748490A patent/CA2748490C/en active Active
- 2009-12-29 WO PCT/US2009/069745 patent/WO2010078373A1/en active Application Filing
- 2009-12-29 MX MX2011007065A patent/MX2011007065A/es active IP Right Grant
- 2009-12-29 DK DK09803976.1T patent/DK2379511T3/en active
- 2009-12-29 EP EP09803976.1A patent/EP2379511B1/en active Active
- 2009-12-29 ES ES09803976T patent/ES2531009T3/es active Active
- 2009-12-29 SI SI200931126T patent/SI2379511T1/sl unknown
- 2009-12-29 PT PT98039761T patent/PT2379511E/pt unknown
- 2009-12-29 JP JP2011543723A patent/JP5788806B2/ja active Active
-
2015
- 2015-07-30 JP JP2015150379A patent/JP2016006082A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SI2379511T1 (sl) | 2015-03-31 |
WO2010078373A1 (en) | 2010-07-08 |
JP2012514008A (ja) | 2012-06-21 |
ES2531009T3 (es) | 2015-03-09 |
EP2379511B1 (en) | 2014-12-17 |
CA2748490A1 (en) | 2010-07-08 |
CA2748490C (en) | 2016-10-04 |
DK2379511T3 (en) | 2015-01-12 |
JP5788806B2 (ja) | 2015-10-07 |
EP2379511A1 (en) | 2011-10-26 |
EP2862854A1 (en) | 2015-04-22 |
PT2379511E (pt) | 2015-02-27 |
JP2016006082A (ja) | 2016-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011007065A (es) | Analogos de dicetopiperazina substituida para usarse como agentes de suministro de farmaco. | |
UA101002C2 (ru) | ПРОИЗВОДНЫЕ ТЕТРАГИДРОИМИДАЗО[1,5-а]ПИРАЗИНА, СПОСОБ ПОЛУЧЕНИЯ И ИХ МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ | |
EA201001368A1 (ru) | Гетероциклические производные мочевины и способы их применения-211 | |
MY143565A (en) | Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof | |
UA99141C2 (ru) | Замещенные производные индазола, активные в качестве ингибиторов киназы | |
ATE514699T1 (de) | Substituierte pyrrolopyrazolderivate als kinaseinhibitoren | |
MX2020012868A (es) | Metodos y composiciones para trastornos del sue?o y otros trastornos. | |
TNSN08326A1 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
TNSN07341A1 (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
WO2012054500A3 (en) | Compositions for drug administration | |
HK1157337A1 (es) | ||
MX2009011997A (es) | Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos. | |
UA92637C2 (en) | Pyridine[3,4-b]pyrazinones | |
TW200637874A (en) | Peptides with neuropeptide-2 receptor (Y2R) agonist activity | |
WO2007149406A3 (en) | Modified coagulation factor ix polypeptides and use thereof for treatment | |
MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
MX2009014235A (es) | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. | |
NZ593110A (en) | pteridinone derivatives as MODULATORS OF TOLL-LIKE RECEPTORS | |
MX2010003927A (es) | Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteinas cinasas b. | |
NZ700182A (en) | Parenteral formulations for administering macrolide antibiotics | |
MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
TW200731975A (en) | Novel combinations of medicaments for the treatment of respiratory diseases | |
EA201001859A1 (ru) | Гетероциклические производные мочевины и способы их применеия | |
CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |